BRISTOL MYERS SQUIBB
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
Phase 2
Completed
- Conditions
- Venous ThrombosisPulmonary Embolism
- Interventions
- First Posted Date
- 2004-11-23
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1238
- Registration Number
- NCT00097357
- Locations
- 🇵🇷
Local Institution, Ponce, Puerto Rico
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program
- Conditions
- Hepatitis BChronic Disease
- First Posted Date
- 2004-11-16
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00096811
- Locations
- 🇮🇱
Local Institution, Zefat, Israel
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection
- First Posted Date
- 2004-11-16
- Last Posted Date
- 2010-08-10
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 69
- Registration Number
- NCT00096785
- Locations
- 🇹🇭
Local Institution, Bankok, Thailand
🇺🇸Local Insitution, New York, New York, United States
Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects
Completed
- Conditions
- HIV Infection
- Interventions
- Drug: LPV/RTV + 2NRTIs
- First Posted Date
- 2004-11-16
- Last Posted Date
- 2011-04-13
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 200
- Registration Number
- NCT00096746
- Locations
- 🇿🇦
Local Institution, Rugby, Western Cape, South Africa
🇺🇸Local Instution, Lexington, Kentucky, United States
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Antidepressant + Placebo
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1200
- Registration Number
- NCT00095758
- Locations
- 🇺🇸
Local Institution, Middleton, Wisconsin, United States
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Antidepressant + Placebo
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1200
- Registration Number
- NCT00095823
- Locations
- 🇺🇸
Local Institution, Middleton, Wisconsin, United States
BMS-599626 in Patients With Advanced Solid Malignancies
Phase 1
Completed
- Conditions
- CancerMetastases
- Interventions
- Drug: panHer
- First Posted Date
- 2004-11-08
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 60
- Registration Number
- NCT00095537
- Locations
- 🇺🇸
Local Institution, Los Angeles, California, United States
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2004-11-08
- Last Posted Date
- 2011-04-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 496
- Registration Number
- NCT00095550
- Locations
- 🇷🇺
Local Institution, St. Petersburg, Russian Federation
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Irbesartan/HCTZ
- First Posted Date
- 2004-11-04
- Last Posted Date
- 2011-04-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 645
- Registration Number
- NCT00095394
- Locations
- 🇷🇺
Local Institution, St. Petersburg, Russian Federation
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
Phase 4
Completed
- Conditions
- Albuminuria
- Interventions
- First Posted Date
- 2004-11-03
- Last Posted Date
- 2011-04-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 400
- Registration Number
- NCT00095290
- Locations
- 🇬🇧
Local Institution, Derby, West Midlands, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath